Julio Vera

Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression

B. Pützer, Shailendra Gupta, Olaf Wolkenhauer, 2023, BMC Chemistry.

Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy

A. Wessely, Harald Knorr, B. Schuler-Thurner, 2024, Journal for ImmunoTherapy of Cancer.

Power-law Models of Signal Transduction Pathways Power-law Models of Signal Transduction Pathways

J. Banga, E. Balsa-Canto, Olaf Wolkenhauer, 2022 .

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms

V. Santini, B. Peruzzi, U. Oelschlaegel, 2024, Leukemia.

Identifying biomarkers and novel therapeutic targets in uveal melanoma

A. Wessely, Elias A T Koch, M. Heppt, 2023, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.